1. Yum SI. Transdermal therapeutic systems and rate controlled drug delivery. Med Prog Technol. 1989;15(1/2):47–52.
2. Cleary GW (1993) The first two decades of transdermal delivery systems and a peek into the 1990’s. In: Gurny R, Teubner A, editors. Dermal and transdermal drug delivery. APV Paperback, vol 31. Wissenschaftliche Vertragsgesellschaft Stuttgart, pp 13–32
3. Bos JD, Das PK, Kapsenberg ML. The skin immune system (SIS). In: Bos JD, editor. Skin immune system (SIS): cutaneous immunology and clinical immunodermatology. 2nd ed. Boca Raton: CRC Press; 1997. pp. 9–16.
4. Naik A, Kalia YN, Guy RH. Transdermal drug delivery: overcoming the skin’s barrier function. Pharm Sci Technol To. 2000;3(9):318–26.
5. Pfister WR Transdermal and dermal therapeutic systems: current status. In: Gosh TK, Pfister WR, Yum SI, editors. Transdermal and topical drug delivery systems. Buffalo Grove: Interpharm Press Inc; 1997. pp 33–112 (Pharmacopoea Europaea 7.8, Chapter 2.9.4–1)